DEUTSCHE BANK AG\
BankPosition in ACAD — Acadia Pharmaceuticals Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ACAD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,521,301
-$12,186,313 QoQ
Shares Held
257,759
-69.3% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ACAD ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,521,301 | 257,759 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $18,707,614 | 840,414 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $22,131,744 | 828,594 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $32,483,747 | 1,522,200 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,845,795 | 734,622 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,633,464 | 760,594 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $19,128,902 | 1,042,447 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $24,261,257 | 1,577,455 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $20,185,652 | 1,242,194 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $19,011,990 | 1,028,231 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $32,106,056 | 1,025,425 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,393,820 | 66,882 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $33,434,343 | 1,396,006 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,554,216 | 454,528 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,916,463 | 183,195 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,902,410 | 177,409 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $977,422 | 69,370 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,878,769 | 77,571 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,996,922 | 85,558 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,806,539 | 168,967 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,293,697 | 135,043 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $29,490,147 | 1,143,029 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $55,951,821 | 1,046,611 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $41,997,449 | 1,018,120 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $52,481,132 | 1,082,755 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $54,228,084 | 1,283,505 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||